Phase I study to assess the safety and tolerability of olaparib in combination with bevacizumab in patients with advanced solid tumours. (British journal of cancer, 2012)

(untitled) - Dean, E; Middleton, M; Pwint, T; Swaisland, H; Carmichael, J; Goodege-Kunwar, P; Ranson, M